RecruitingNot ApplicableNCT06761404
Non-invasive VNS in Stroke Recovery
Sponsor
The Methodist Hospital Research Institute
Enrollment
60 participants
Start Date
Apr 15, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
To evaluate feasibility and effectiveness of non-invasive VNS to enhance stroke recovery
Eligibility
Min Age: 18 Years
Inclusion Criteria8
- Symptomatic ischemic or hemorrhagic stroke verified by computerized axial tomography or magnetic resonance imaging resulting in hemiparesis (MRC 1-4).
- Age more than 18, Male or Female, All racial and ethnic groups
- Entry into the study \>6 months post onset
- Patients who can safely undergo taVNS
- Able to follow 2 step commands
- Modified Ashworth Scale Score =\<3 in the involved upper extremity
- Passive range of motion within functional ranges at the shoulder, elbow, wrist and hand
- UFM =\< 60 (scale 0-66)
Exclusion Criteria8
- Patients with history of severe alcohol or drug abuse, psychiatric illnesses like severe depression, poor motivational capacity, or severe language disturbances, particularly of receptive nature or with serious cognitive deficits (defined as unable to follow study instructions).
- Patients with bilateral paresis, or weakness or sensory damage due to peripheral causes (e.g. peripheral nerve injury, muscle or orthopedic injury etc.)
- Subjects with contraindication to MRI of the brain
- Patients with severe uncontrolled medical problems (e.g. cardiovascular disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer or renal disease, any kind of end-stage pulmonary or cardiovascular disease, or a deteriorated condition due to age, epilepsy or others).
- Patients with unstable cardiac arrhythmia, reentry tachycardia.
- Pregnancy
- Patients with pacemakers or stimulators that interfere with the stimulation, or other investigational devices or drugs
- Non-English speaking individuals will only be eligible if they can provide the appropriate translator for all the sessions of the study as no funding is available to pay for such services. However we plan to include them once funding has been secured in the subsequent larger trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEtaVNS
Experimental. The current will be increased gradually for both sham and real stimulation at the beginning of the 90-minute stimulation to lessen the itchy/numb skin sensation and to create the same skin sensation for subject blinding.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06761404
Related Trials
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
NCT066159731 location
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
NCT034017621 location
Strategy Training for Optimizing Attention for Individuals With Spatial Neglect
NCT073318961 location
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
NCT0640296811 locations
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT0506521663 locations